Cotargeting of BCL2 with Venetoclax and MCL1 with S63845 Is Synthetically Lethal <i>In Vivo</i> in Relapsed Mantle Cell Lymphoma - Concepedia

Concepedia

Publication | Closed Access

Cotargeting of BCL2 with Venetoclax and MCL1 with S63845 Is Synthetically Lethal <i>In Vivo</i> in Relapsed Mantle Cell Lymphoma

72

Citations

38

References

2019

Year

Dana Průková, Ladislav Anděra, Zuzana Nahácka, Jana Karolová, Michael Svatoň, Magdalena Klánová, Ondřej Havránek, J. Soukup, Karla Svobodová, Zuzana Zemanová,

Clinical Cancer Research

Abstract

Our data strongly support investigation of venetoclax in combination with S63845 as an innovative treatment strategy for chemoresistant MCL patients with adverse cytogenetics in the clinical grounds.

References

	Year	Citations

Page 1